PHARMACOKINETIC ANALYSIS OF beta-GLUCAN FOLLOWING ADMINISTRATION OF PGG-GLUCAN, A NOVEL IMMUNOMODULATOR BEING DEVELOPED FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER.

Marier J. F.; Jomphe C.; Beliveau M.; Lowe J.; Mattson P.; Walsh R.; Patchen M. L.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >PHARMACOKINETIC ANALYSIS OF beta-GLUCAN FOLLOWING ADMINISTRATION OF PGG-GLUCAN, A NOVEL IMMUNOMODULATOR BEING DEVELOPED FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER.

【24h】

PHARMACOKINETIC ANALYSIS OF beta-GLUCAN FOLLOWING ADMINISTRATION OF PGG-GLUCAN, A NOVEL IMMUNOMODULATOR BEING DEVELOPED FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER.

机译：继PGG-Glucan给药后开发的新型免疫调节剂PGG-Glucan的药代动力学分析，该药物已被开发用于治疗非小细胞肺癌。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2014年第1期|共2页
作者
Marier J. F.; Jomphe C.; Beliveau M.; Lowe J.; Mattson P.; Walsh R.; Patchen M. L.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. PHARMACOKINETIC ANALYSIS OF beta-GLUCAN FOLLOWING ADMINISTRATION OF PGG-GLUCAN, A NOVEL IMMUNOMODULATOR BEING DEVELOPED FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER. [J] . Marier J. F., Jomphe C., Beliveau M., Clinical Pharmacology and Therapeutics . 2014,第Suppla1期

机译：继PGG-Glucan给药后开发的新型免疫调节剂PGG-Glucan的药代动力学分析，该药物已被开发用于治疗非小细胞肺癌。
2. Intratumoral administration of cisplatin through a bronchoscope followed by irradiation for treatment of inoperable non-small cell obstructive lung cancer. [J] . Celikoglu F, Celikoglu SI, York AM, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2006,第2期

机译：通过支气管镜对顺铂进行瘤内给药，然后放射治疗无法手术的非小细胞阻塞性肺癌。
3. Retrospective analysis of administration of a combination of docetaxel and carboplatin for advanced non-small cell lung cancer. [J] . Bando H, Miyata J, Sano T, Anticancer Research: International Journal of Cancer Research and Treatment . 2001,第3C期

机译：对多西他赛和卡铂联合治疗晚期非小细胞肺癌的回顾性分析。
4. SAHA Treatment Reveals the Link between Histone Lysine Acetylation and Proteome in Non-small Cell Lung Cancer A549 Cells [C] . Quan Wu, Weiqing Xu, Lejie Cao, ASMS Conference on Mass Spectrometry and Allied Topics . 2014

机译：Saha治疗揭示了非小细胞肺癌A549细胞中组蛋白赖氨酸乙酰化和蛋白质组之间的联系
5. Structure--activity relationship studies of hybrid antitumor agents for the treatment of non-small cell lung cancer. [D] . Ma, Zhidong. 2009

机译：杂合抗肿瘤药治疗非小细胞肺癌的构效关系研究。
6. A Case of Residual Non-Small Cell Lung Cancer Cells Coexisting With Newly Developed Small Cell Lung Cancer Cells in Ascitic Fluid after Chemotherapy for Non-Small Cell Lung Cancer [O] . Sang Hyuk Park, Hyun-Sook Chi, Young Jin Kim, 2014

机译：非小细胞肺癌化疗后腹水中残留的非小细胞肺癌细胞与新开发的小细胞肺癌细胞共存一例
7. Meta-analysis of EGFR tyrosine kinase inhibitors compared with chemotherapy as second-line treatment in pretreated advanced non-small cell lung cancer. [O] . Ning Li, Lu Yang, Wei Ou, 2014

机译：EGFR酪氨酸激酶抑制剂的meta分析与化疗作为预处理的晚期非小细胞肺癌的二线治疗相比较。

PHARMACOKINETIC ANALYSIS OF beta-GLUCAN FOLLOWING ADMINISTRATION OF PGG-GLUCAN, A NOVEL IMMUNOMODULATOR BEING DEVELOPED FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER.

著录项

相似文献

相关主题

期刊订阅